Pfizer Suffered 'Significant Loss Of Control' At McPherson Plant, US FDA Warning Letter Says

Infractions that have delayed Copaxone generic in plant Pfizer acquired when it bought Hospira suggest that pattern of quality issues may be continuing. Warning letter assigns eight tasks related to particulate contamination.